The BIC Biomarker Commercialization project consortium is organizing a free webinar on how to commercialize a biomarker discovery, the last webinar of a series focusing on the biomarker commercialization process.
The focus of this webinar is on the go-to-market phases of the commercialization process.
This webinar introduces the participants to the different biomarker commercialization tools that aim to guide the user through the process of commercializing a biomarker invention.
Webinar programme:
14:00-14:15 CEST Introduction to the BIC Biomarker Commercialization Tools
Valerie Daussin Laurent, Team Leader Business Development, Aalborg University Hospital, Project Leader BIC BRIDGE consortium
14:15-14:30 CEST How SMEs can Best Utilize the Go-to-Market Phases of the Biomarker Commercialization Guide (in connection with the IVDR Roadmap)
Teppo Laaksonen, Network Manager, Turku Science Park Ltd
14:30-14:45 CEST Tuleap Project Management Tool for Biomarker Development Projects
Ewa Zdunczyk, Project Manager at Wroclaw Technology Park
14:45-15:00 CEST BIC Educational Toolbox
Monica Recabarren, Project Leader, Aalborg University Hospital
15:00-15:15 CEST Q&A
Moderator: Teppo Laaksonen, Network Manager, Turku Science Park Ltd
Further information and registration
Contact: Merja Tieaho
The Biomarker Commercialization (BIC BRIDGE) consortium is developing a Biomarker Commercialization Toolset, designed to support, step-by-step, both academic researchers, SMEs and technology transfer office specialists (TTOs) when developing a biomarker-based invention to a commercial product. The BIC toolset includes a Biomarker Commercialization Guide, which covers technical, clinical, commercial and regulatory aspects, a Best Practices Handbook based on experiences from TTOs in the field, a Review Tool for TTOs, a Toolset for the regulatory process, an Educational Toolbox, as well as a Project Management Template. The toolset will be available for free in autumn 2021. The BIC BRIDGE project is funded by Interreg Baltic Sea Region Programme. More information on the project and the tools: https://biomarker.nu/